Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
Filamon LTD
AstraZeneca
Origin Sciences
AstraZeneca
University of Michigan Rogel Cancer Center
Hoffmann-La Roche
Rutgers, The State University of New Jersey
UMC Utrecht
Aveni Foundation
Bayer
Psyence Australia Pty Ltd
ViroMissile, Inc.
National Taiwan University Hospital
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
AstraZeneca
Duke University
AstraZeneca
Essen Biotech
MBrace Therapeutics
Azienda Ospedaliero-Universitaria di Parma
A2 Biotherapeutics Inc.
Eli Lilly and Company
Angiex, Inc.
Poseida Therapeutics, Inc.
MacroGenics
Unity Health Toronto
City of Hope Medical Center
xCures
Daiichi Sankyo
University of Nebraska
Takeda
Cue Biopharma
Eli Lilly and Company
Boehringer Ingelheim
HealthPartners Institute
Adela, Inc
National Institutes of Health Clinical Center (CC)
Imperial College London
Second Life Therapeutics
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)
Var2 Pharmaceuticals
City of Hope Medical Center
MOMA Therapeutics
Mayo Clinic
Memorial Sloan Kettering Cancer Center